384 related articles for article (PubMed ID: 32690139)
1. Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review.
Halsey T; Ologun G; Wargo J; Jenq RR
Semin Hematol; 2020 Jan; 57(1):13-18. PubMed ID: 32690139
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
4. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
[TBL] [Abstract][Full Text] [Related]
5. A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer.
Kim E; Ahn H; Park H
Mamm Genome; 2021 Aug; 32(4):223-231. PubMed ID: 33783613
[TBL] [Abstract][Full Text] [Related]
6. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
Hayase E; Jenq RR
Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
9. How does the gut microbiome influence immune checkpoint blockade therapy?
Almonte AA; Rangarajan H; Yip D; Fahrer AM
Immunol Cell Biol; 2021 Apr; 99(4):361-372. PubMed ID: 33147357
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites.
Malczewski AB; Ketheesan N; Coward JIG; Navarro S
Front Immunol; 2021; 12():624434. PubMed ID: 34305883
[TBL] [Abstract][Full Text] [Related]
11. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.
Park JS; Gazzaniga FS; Wu M; Luthens AK; Gillis J; Zheng W; LaFleur MW; Johnson SB; Morad G; Park EM; Zhou Y; Watowich SS; Wargo JA; Freeman GJ; Kasper DL; Sharpe AH
Nature; 2023 May; 617(7960):377-385. PubMed ID: 37138075
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
McQuade JL; Ologun GO; Arora R; Wargo JA
Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
14. Can gut microbes predict efficacy and toxicity of combined immune checkpoint blockade?
Lam KC; Goldszmid RS
Cancer Cell; 2021 Oct; 39(10):1314-1316. PubMed ID: 34637746
[TBL] [Abstract][Full Text] [Related]
15. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.
Reens AL; Cabral DJ; Liang X; Norton JE; Therien AG; Hazuda DJ; Swaminathan G
Front Immunol; 2021; 12():643255. PubMed ID: 34054810
[TBL] [Abstract][Full Text] [Related]
18.
Sun S; Luo L; Liang W; Yin Q; Guo J; Rush AM; Lv Z; Liang Q; Fischbach MA; Sonnenburg JL; Dodd D; Davis MM; Wang F
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27509-27515. PubMed ID: 33077598
[TBL] [Abstract][Full Text] [Related]
19. Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy.
Davar D; Zarour HM
Clin Cancer Res; 2022 Oct; 28(20):4370-4384. PubMed ID: 35748749
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responses.
Wong MK; Barbulescu P; Coburn B; Reguera-Nuñez E
Microbes Infect; 2021; 23(6-7):104804. PubMed ID: 33652120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]